Join
Live feed
·
PRReleasevia Quantisnow
BrainsWay Ltd. logo

BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

ByQuantisnow·Wall Street's wire, on your screen.
BWAY· BrainsWay Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BWAY (BrainsWay Ltd.) and more on Quantisnow.